Introduction
Receptor tyrosine kinases (RTK) regulate cell proliferation and differentiation when activated upon binding to their respective growth factor ligands, and when deregulated may lead to the development of cancer (1, 2) . The ErbB subfamily of RTKs contains four members: ErbB1 (EGFR, HER1), ErbB2 (Neu, Her2), ErbB3 (HER3), and ErbB4 (HER4), which have been strongly implicated in the development of human cancers (2) .
Activation of ErbB receptors induces receptor dimerization, which transmits a signal across the plasma membrane and activates the intracellular tyrosine kinase domain (3, 4) . This in turn leads to trans-autophosphorylation on tyrosine residues that function as docking sites for signal transducing molecules (5) . Among the most prominent signaling pathways activated by ErbB receptors is the Ras/MAPK cascade (6) .
Activated Ras can induce the release of growth factors including EGF-like ligands such as amphiregulin, TGFα, HB-EGF and NRG (7, 8) , thereby inducing receptor phosphorylation via an autocrine or paracrine loop. Constitutively activated Ras can also induce ErbB phosphorylation in a ligand-independent manner (9) . Ras signaling is aberrantly activated in a large fraction of human tumors (1, 10) . Because Ras signaling represents a convergence point for numerous diverse extracellular signals, Ras and its effectors are appropriate targets for therapeutic intervention. Abnormal function of the ErbB receptors and their ligands is also involved in human cancer and these receptors are currently targets of an increasing number of cancer drugs (2, 11) .
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Author Manuscript Published OnlineFirst on January 21, 2011; DOI: 10.1158/0008-5472. CAN-10-2887 Recently we demonstrated that ErbB1 interacts with the multifunctional protein, nucleolin (12) , a ubiquitously expressed acidic phosphoprotein with key functions in transcription and in the synthesis and maturation of ribosomes (13, 14) . Nucleolin is thus involved in critical aspects of transcriptional regulation, cell proliferation, and cell growth (15, 16) . Nucleolin was originally identified as a nuclear protein localizing primarily to the nucleoli, but is now appreciated to undergo nuclear-cytoplasmic shuttling and to also be present on the cell surface of some types of cells (14, 17, 18) .
Inhibition of cell-surface nucleolin and nucleolin activities suppresses cell and tumor growth (13, (19) (20) (21) in breast, prostate and glioma cell lines, which also express high levels of ErbB receptors and/or activated Ras protein. An aptamer targeting nucleolin, AS1411, is in phase II clinical trial for relapsed/refractory acute myeloid leukemia (22) .
We recently identified non-nuclear nucleolin as an ErbB receptor-interacting protein (12) . This interaction leads to receptor dimerization and activation as well as to colony growth in soft agar. The ErbB1 juxtamembrane region containing the nuclear localization sequence (NLS), which is important for ErbB1 kinase activation (23) , is also important for nucleolin-ErbB1 interaction and for nucleolin-induced ErbB1 dimerization and activation (24) . In addition we demonstrated that this effect is mediated by the 212 C-terminal amino acids of nucleolin (24) . Thus it was suggested that the crosstalk between nucleolin and ErbB proteins might be related to tumor growth.
Author Manuscript Published OnlineFirst on January 21, 2011; DOI: 10.1158/0008-5472. CAN-10-2887 In the present study we demonstrate a crosstalk between nucleolin, ErbB1 and Ras proteins. All three typical Ras isoforms (H-, K-and N-Ras) interact with nucleolin.
The 212 C-terminal amino acids of nucleolin are sufficient for this interaction and colocalize with Ras at the plasma membrane. Moreover, we demonstrate that GTPbound Ras strongly enhances ErbB1/nucleolin interaction. Finally, we demonstrate that expression of activated H-Ras(G12V), nucleolin and ErbB1 synergistically enhance cell transformation, as evidenced by increased colony formation in soft agar and increased tumor volume in nude mice.
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Materials and Methods

Materials and Buffers
Human recombinant EGF was purchased from Boehringer Mannheim. Polyclonal anti-ErbB1 antibodies (Abs), monoclonal anti-phosphotyrosine , anti-GFP and antinucleolin were purchased from Santa Cruz Biotechnology (CA, USA). Monoclonal anti-pan-Ras and polyclonal anti-Ras were purchased from Calbiochem. Monoclonal anti p-Erk were purchased from New England Biolabs inc. Anti-β actin and anti-HRas monoclonal antibodies were from Santa Cruz Biotech (Santa Cruz, CA).
Monoclonal anti β-tubulin and all other reagents were from Sigma. GRO (AS1411) aptamer and CRO (inactive oligomer) were synthesized as previously described (13, 22) . Salirasib (FTS), a farnesylcysteine mimetic, was a gift from Concordia Pharmaceuticals (Fort Lauderdale, FL) and was prepared for experiments as described previously (25) . HNTG buffer contained 20 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol. Solubilization buffer contained 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EGTA, 1 mM EDTA, 1.5 mM MgCl2, 10% glycerol, 2 mM sodium vanadate, 1 mM phenylmethylsulfonylfluoride, Transfection, USA) or using calcium phosphate (CaPO4) precipitation. Cell lysates were prepared 48 h following transfection as described. Preparation of HEK-293 cells stably expressing the ErbB-1 receptor was previously described (24) . Expression vectors GFP-ErbB1, GFP-H-Ras (12V) or pcDNA3-H-Ras(12V) and DsRed-nucleolin were introduced by JetPeI transfection into MDCK cells either alone or together. The neomycin (G418)-resistant colonies were examined for ErbB-1, Ras or nucleolin expression and several colonies (3 clones from each combination) were selected for further analysis. NIH3T3 were obtained from ATCC and routinely grown in a humidified incubator at 37oC with 5% CO2. Cells were grown in DMEM supplemented with 10% bovine serum (BS; Life Technologies No. 16170078), 62.5 μg/mL penicillin and 100 μg/mL streptomycin (Hyclone Laboratories, Logan, Utah).
NIH3T3 were transfected with the vector pZIP, or pZIP-H-Ras (12V), using Lipofectamine 2000 (Invitrogen), according to the manufacturer's directions, and geneticin-resistant cells were selected to be examined by western blot.
DNA Constructs
GFP-ErbB1 was provided by Marcello Erlich, Tel Aviv University, Israel. Expression vectors for pEGFP-nucleolin, DsRed-nucleolin (DsRed-NCL) and DsRed-nucleolin mutants were previously described (12, 24) . Flag-nucleolin expression vectors were generously donated by both James A Borowiec (New York University, USA) and Paula J Bates (University of Louisville, USA). N-Ras and N-Ras(13V) expression
Research. vectors were previously described (26) . GFP-K-Ras, GFP-K-Ras(12V), GFP-H-Ras and GFP-H-Ras(12V) were previously described (27) .
Lysate Preparation, Immunoprecipitation and Immunoblotting
Cells were exposed to the indicated stimuli and solubilized in solubilization buffer.
Lysates were cleared by centrifugation. For direct electrophoretic analysis, boiling gel sample buffer was added to cell lysates. For other experiments, Abs were first coupled to anti-mouse IgG agarose for 1 h at RT; alternatively, anti-Flag M2 agarose beads (Sigma) were used. Proteins in the lysate supernatant were precipitated with aliquots of the beads-antibody complexes for 2 h at 4°C. The immunoprecipitates were washed three times with HNTG, resolved by SDS-polyacrylamide gel electrophoresis (28) and electrophoretically transferred to nitrocellulose membrane.
Membranes were blocked for 1 h in TBST buffer (0.02 M Tris-HCl pH 7.5, 0.15 M NaCl, and 0.05% Tween 20) containing 6% milk, blotted with 1 µg/ml primary Abs for 2 h, followed by 0.5 µg/ml secondary antibody linked to horseradish peroxidase.
Immunoreactive bands were detected with the enhanced chemiluminescence reagent (Amersham Corp, UK).
Imaging
HEK-293T cells were plated on glass coverslips placed in 6 well plates at a density of paraformaldehyde at room temperature for 30 min. For triple staining, fixed slides were immunostained with rabbit anti-ErbB1 antibodies (1:100) followed by Alexa fluor 405-labeled donkey anti rabbit secondary antibodies (1:1000; Invitrogen, Eugene, OR) as previously described (29) . Cells were examined by fluorescent microscopy at 63x magnification with Zeiss 510 META confocal microscopy.
Soft Agar Assay
Cells were seeded at a density of 1,000 cells/well in 96 well plates in DMEM containing 10% FBS. The cells were mixed with 0.05 ml (per well) of 0.33% Noble agar, and the mixture was poured onto a layer of 0.05 ml 1% Noble agar in DMEM containing 10% FBS. The upper layer of the agar was covered with 0.1 ml of culture medium. Assays were performed at least six times. The number of colonies with size above 0.01 mm 2 was estimated on day 8, using a binocular and light microscopy with the image analyzer program Image Pro-Plus. Results shown are the mean ± SD of 6 determinations from each of the clones used.
Tumor Growth in Nude Mice
MDCK cells harboring nucleolin, ErbB1, H-Ras(12V) and their combinations were implanted into nude nice. Nude CD1-Nu mice (25-30 g) were housed in barrier facilities on a 12-h light/dark cycle. Food and water were supplied ad libitum. On day zero, 2 ×10 6 cells of each clone in 0.1 ml of PBS were implanted subcutaneously just above the right femoral joint. Tumor volumes were then monitored on the indicated days as described previously (30) .
RESULTS
Analysis of nucleolin/Ras interactions
In our previous reports we have demonstrated that nucleolin interacts with each of the four ErbB receptors and that this interaction has functional consequences, as it induces ligand-independent receptor activation (12) . In related studies we found that constitutively active Ras also induces receptor phosphorylation in a ligandindependent manner (9). It was not known whether the two phenomena are related each to the other, a possibility that might have a strong impact on cell transformation.
We therefore investigated whether Ras can affect nucleolin-ErbB interaction. We first examined the ability of nucleolin to co-precipitate with Ras isoforms. Cells coexpressing Flag-nucleolin and GFP-tagged wild type (wt) or constitutively active HRas or K-Ras were lysed and subjected to immunoprecipitation of nucleolin using anti-Flag Abs, followed by immunoblotting for Ras with anti-GFP Abs ( Figure 1A ).
As a control, cells were transfected with GFP-H-Ras(12V) and lysates were precipitated with anti-Flag Abs; no Ras precipitation was observed ( Figure 1A) . Similarly, cells expressing wt or constitutively active N-Ras were immunoprecipitated with antinucleolin Abs to pull down the endogenous nucleolin. The blots were then exposed to anti-Ras Abs ( Figure 1B ErbB1. Therefore it seems that there is a crosstalk between ErbB1, nucleolin and Ras, either directly or indirectly. We do not know whether these interactions occur simultaneously.
We then examined the interaction between ErbB1, nucleolin and Ras in human cancer cell lines without ectopic expression of any of these proteins. We used two cell lines: the colon cancer cell line DLD-1 that endogenously expresses ErbB1, nucleolin and mutant K-Ras(12V) and the glioblastoma cell line U87 that overexpresses ErbB1 and exhibits high Ras-GTP levels. Cell lysates were subjected to immunoprecipitation using anti-nucleolin Abs and immunoblotted with either anti-ErbB1 or anti-Ras Abs.
As a negative control, lysates were precipitated with anti-GFP Abs. In both cell lines, nucleolin precipitated ErbB1 and Ras proteins ( Figure 2D ). These results support the conclusion that nucleolin interactions with ErbB1 and Ras occur in cancer cells expressing these proteins endogenously.
The 212 amino acid C-terminal region of nucleolin (212C-ter) interacts with Ras at the plasma membrane and is required for nucleolin/Ras interactions
We have shown previously that the C-terminal 212 amino acid region of nucleolin (212C-ter, scheme in Figure 3A) , which contains the RNA binding domain 4 (RBD4, residues 498-645) and the glycine-arginine rich C-terminal region (GAR, residues 645-710), is both required and sufficient for nucleolin interaction with ErbB1 (24 Ras isoforms and GFP-nucleolin deletion mutants (Figure 3B-D) . K-Ras(12V), HRas(12V) and N-Ras(13V) each immunoprecipitated effectively GFP-nucleolin 212-Cter and less effectively the individual GFP-tagged-GAR or -RBD4 domains. In contrast, the GFP-tagged-N-terminal mutant of nucleolin lacking RBD4/GAR (residues 1-498) did not precipitate with any of the Ras isoforms. These results suggest that the 212 C-terminal amino acid residues of nucleolin are both essential and sufficient for nucleolin-Ras interaction, as they are for nucleolin-ErbB1 interaction.
Next we examined whether nucleolin or its isolated 212 C-terminal amino acids colocalize with Ras at the plasma membrane, a major site of the interaction between nucleolin and ErbB1 (12) and of Ras (27) . To this end we cotransfected HEK 293T cells with GFP-K-Ras(12V) or GFP-H-Ras(12V) and either pDsRed empty vector, pDsRed-nucleolin, pDsRed-212C-ter or pDsRed-N-ter (negative control). The subcellular localization of the labeled proteins was studied by dual fluorescent confocal microscopy. Consistent with our earlier studies (27) , GFP-K-Ras(12V) was localized mainly to the plasma membrane but also to cytoplasmic vesicular compartments ( Figure 4 ). Full-length pDsRed-nucleolin (RFP-NCL) was mainly localized to the nucleus, and also to the cytosol and plasma membrane, as expected GFP-K-Ras at the plasma membrane (Figure 4) . Consistent with the fact that the nuclear localization sequences of nucleolin reside in its N-terminus, the majority of DsRed-212C-ter was not preferentially localized to the nucleus but was distributed throughout the nucleus and the cytoplasm, whereas DsRed-N-ter was localized exclusively to the nucleus, in which no GFP-K-Ras(12V) was detected. Thus, GFP-KRas(12V) and DsRed-N-ter showed no co-localization (Figure 4 These results also indicate that nucleolin 212 C-terminal amino acids are important for the interaction with both ErbB1 and Ras.
All Ras isoforms reduce EGF-induced reduction in the levels of ErbB1
Previously, we demonstrated that overexpression of nucleolin reduces EGF-mediated ErbB1 degradation (12 Figure 6A . We subsequently examined the possibility that the three proteins synergistically enhance cell transformation, by soft agar assays using the MDCK clones described above.
Cells were plated in soft agar and maintained in culture for 8 days before quantitating the number and size of colonies able to grow in an anchorageindependent manner. Results of a typical experiment ( Figure 6A We then examined whether these effects are mediated by nucleolin-212 Cter region which is important for the interaction with ErbB1 and Ras. We prepared clones that express stably either empty vector, nucleolin-212 Cter alone, nucleolin-212 Cter and
ErbB1, H-Ras(12V) alone, nucleolin-212 Cter and H-Ras(12V), ErbB1 and H-Ras(12V)
or the combination of all three proteins, and three individual clones from each transfection were selected (typical clones are shown in Figure 6B ). As shown the 212-Cter was sufficient to mediate the anchorage independent growth effect when coexpressed with active Ras and ErbB1 ( Figure 6B ). These results strongly suggest that the combined expression of the three proteins synergistically enhance cell transformation and that the 212 C-terminal amino acids of nucleolin is sufficient. 
nucleolin + ErbB1; nucleolin + H-Ras-(12V); or nucleolin, ErbB1 and H-Ras-(12V).
Tumor volumes were monitored for 25 days following injection (Figure 7) . Mock, nucleolin, or nucleolin + ErbB1 transfectants formed tumors that were only barely detectable and H-Ras(12V) or nucleolin + H-Ras(12V) transfectants formed relatively small tumors. In contrast, cells expressing nucleolin, ErbB1 and H-Ras(12V) formed large tumors (Figure 7 , p<0.01) supporting the conclusion that they synergize in induction of cell transformation and that all three proteins are required for maximal transforming activity.
DISCUSSION
Nucleolin is a major component of the nucleolus and is also found in other cellular compartments (31) . This key protein is involved in various aspects of ribosome biogenesis from transcriptional regulation to the assembly of pre-ribosomal particles.
One study described interactions between nucleolin and K-Ras in the nucleolus (32) .
Other reports suggest that it could also play an important role in non-nucleolar functions (14) . Recently we described a novel interaction between nucleolin and ErbB receptors at the plasma membrane and that this interaction enhances ErbB-mediated responses (12) . In other experiments we showed that constitutively active Ras isoforms induce ErbB4 receptor phosphorylation in a ligand-independent manner, suggesting a direct intracellular positive control of Ras or its signals over ErbB4 (9) . Our experiments show that nucleolin is capable of interacting with all three Ras isoforms, H-Ras, K-Ras and N-Ras. Previously, we found that H-Ras(12V) protein interacts specifically with galectin-1 (25, 33) and that K-Ras(12V) protein interacts specifically with galectin-3 (34) . We also showed that these interactions are the driving forces that promote nanoclustering of active H-Ras (35) and of active K-Ras (36) proteins in the inner leaflet of the plasma membrane, processes known to promote robust digital signaling (37, 38) . However, no escort proteins of N-Ras were reported.
In the present study we have identified for the first time nucleolin as such an escort protein of N-Ras. Nucleolin is however less selective than galectins, first because it binds all Ras isoforms and second because it binds both the GDP-bound and GTPbound forms of Ras. Thus, nucleolin/Ras interactions are independent of the GDP/GTP conformations of Ras proteins. Clearly then the interactions of Ras isoforms with nucleolin differ from those of H-and K-Ras proteins with galectins because only the latter depend on Ras-GTP (33, 34) . However, the GTP-binding state of Ras is important for the interactions of ErbB1 and nucleolin, as discussed below.
The three highly homologous Ras proteins differ mainly in their hypervariable (hvr) region upstream of the common C-terminal farnesyl cysteine carboxymethylester (39) (40) (41) (42) . Because all three interact with nucleolin it is reasonable to assume that either the C-terminal farnesylcysteine and/or the domains upstream of the hvr that they share in common may be involved in nucleolin/Ras interactions. Nucleolin was reported previously to interact with K-Ras4B but not with H-Ras in the nucleolus (32) . In a study published during the final preparation of our manuscript it was reported that nucleolin from post-nuclear supernatants of BHK cells interacts with K-Ras but not HRas (43) . The basis for this discrepancy is currently unclear. The latter study showed that a GFP-fusion protein containing only the hvr domain of K-Ras4B was sufficient for interaction with nucleolin, consistent with their and our findings that Ras/nucleolin interactions are not affected by the GTP-binding status of Ras.
Additional experiments are required to determine which regions in Ras are critical for the interactions with nucleolin.
Using mutational analysis we found that the interaction between nucleolin and Ras is mediated specifically by the 212 C-terminal amino acids of nucleolin and not by the Nterminal domain of the protein. This interaction appears to occur predominantly at the plasma membrane since the 212 C-terminal nucleolin mutant overlaps there with KRas(12V) and with H-Ras(12V). Interestingly, this very same domain is also important for ErbB1/nucleolin interaction (24) , suggesting that the nucleolin 212 C-terminal region is involved in the interactions of nucleolin with ErbB1 and Ras to enhance cell transformation and cancer development.
Nucleolin is a major nucleolar phosphoprotein of exponentially growing eukaryotic cells (14) and it is overexpressed in highly proliferating cells (44) . Nucleolin was originally identified as a nucleolar protein, but is now considered to be a shuttle 14, 17, 18 ).
Interestingly it is also found on the cell surface of a wide range of cancer cells and is used as a diagnostic marker for cancer and for the development of anti-cancer drugs (18, 20, 44) .
The ErbB subfamily of receptor tyrosine kinases has been implicated, more than other growth factor receptors, in the development of several human cancers (2) . Elevated CAN-10-2887 the GDP/GTP state of Ras, as shown by the fact that the interaction is strongly increased Cells were then treated with 10 μM GRO or 10 μM CRO (control oligonucleotide) for four days. Proliferation was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously (13) . Data are presented as percentage of control untreated cells (mean±SE, n=3). 
